Pfizer’s First Of Its Kind Gene Therapy Shines In Phase 3 Trials For Treatment of Hemophilia A
Giroctocogene fitelparvovec, a novel gene therapy, demonstrated superiority to routine therapy in treating hemophilia A. Giroctocogene fitelparvovec resulted in a ...